Unihealth Hospitals Ltd

- Target EBITDA margins expected around mid-20% by 24 months post facility commissioning (Page 23). - FY27 outlook: Doubling revenue with about 600+ beds, 60% occupancy (~300 beds occupied), targeting INR75 lakh to INR1 crore average revenue per occupied bed annually (Page 19). - Consolidated EBITDA margins expected to stay in early 30%s despite expansions due to mix of mature and new facilities (Page 18). - PAT margin guidance: Expecting 8-12%, settling around 10-12% in the near term; slight dip from FY26 exceptional margins due to rise in finance costs & depreciation from rapid expansion and new equipment (Page 19). - Revenue growth expected at 15%-25% yearly, driven by bed additions, super specialty services, and medical tourism/consultancy verticals (Page 17). - Navi Mumbai facility projection: Break-even expected by Q2 FY27, supported by higher than expected revenue per occupied bed (Page 6-7). - 2028 target: 1,000 commissioned beds with ~55-60% occupancy, aiming annual revenues around INR100-110 crores at INR30,000 ARPOB (Page 7). Overall, strong growth supported by expanding bed capacity, diversification, and increasing occupancy with steady margins expected.

The provided pages from the Unihealth Hospitals Limited conference transcript do not contain explicit information regarding the current or expected order book or pending orders. The discussion primarily focuses on bed capacities, operational milestones, revenue targets, occupancy rates, margins, and geographical expansion plans (India and Africa). If you need details about order book or pending orders specifically, they are not mentioned in the supplied sections of the document. Please provide a different page or section if available, or clarify if you want information on project pipelines or capacity expansion plans indirectly related to orders.